1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Breast Cancer Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Breast Cancer Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Breast Cancer Therapeutics Market Regional Analysis
6.2 North America Breast Cancer Therapeutics Market Revenue 2020-2030 (US$ Million)
6.3 North America Breast Cancer Therapeutics Market Forecast Analysis
7. North America Breast Cancer Therapeutics Market Analysis – by Drug Therapy
7.1 Targeted Drug Therapy
- 7.1.1 Overview
- 7.1.2 Targeted Drug Therapy: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Hormonal Drug Therapy
- 7.2.1 Overview
- 7.2.2 Hormonal Drug Therapy: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Chemotherapy
- 7.3.1 Overview
- 7.3.2 Chemotherapy: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Immunotherapy/Biological Therapy
- 7.4.1 Overview
- 7.4.2 Immunotherapy/Biological Therapy: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Breast Cancer Therapeutics Market Analysis – by Breast Cancer Type
8.1 Hormone Receptor
- 8.1.1 Overview
- 8.1.2 Hormone Receptor: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 HER2+
- 8.2.1 Overview
- 8.2.2 HER2+: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Triple-Negative Breast Cancer
- 8.3.1 Overview
- 8.3.2 Triple-Negative Breast Cancer: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Breast Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Drug Store and Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Drug Store and Retail Pharmacies: North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Online Pharmacies
- 9.3.1 Overview
- 9.3.2 Online Pharmacies : North America Breast Cancer Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Breast Cancer Therapeutics Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Breast Cancer Therapeutics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 North America Breast Cancer Therapeutics Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Breast Cancer Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Breast Cancer Therapeutics Market Breakdown, by Drug Therapy
- 10.2.1.1.2 US: North America Breast Cancer Therapeutics Market Breakdown, by Breast Cancer Type
- 10.2.1.1.3 US: North America Breast Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.2 Canada:
North America Breast Cancer Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Breast Cancer Therapeutics Market Breakdown, by Drug Therapy
- 10.2.1.2.2 Canada: North America Breast Cancer Therapeutics Market Breakdown, by Breast Cancer Type
- 10.2.1.2.3 Canada: North America Breast Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.3 Mexico :
North America Breast Cancer Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Breast Cancer Therapeutics Market Breakdown, by Drug Therapy
- 10.2.1.3.2 Mexico : North America Breast Cancer Therapeutics Market Breakdown, by Breast Cancer Type
- 10.2.1.3.3 Mexico : North America Breast Cancer Therapeutics Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Eli Lilly and Co
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Eisai Co Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Novartis AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 AstraZeneca Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pfizer Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Gilead Sciences Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck & Co Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Genentech Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Teva Pharmaceutical Industries Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Amgen Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Breast Cancer Therapeutics Market
